Digoxin Tablet
Product Images NDC 51655-403

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 51655-403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure diagram of Digoxin, showing its steroid-based molecular framework with attached sugar moieties. The structure includes multiple rings, hydroxyl groups, methyl groups, and oxygen atoms characteristic of the digoxin molecule.*

FDA Label Image

Label (51655 403 52 Rev A 04 23 Nhc)

Label for Digoxin Tablets USP 125 mcg (0.125 mg), oral tablet form, containing 30 tablets. The label includes storage instructions, Rx only designation, and the labeler Northwind Health Company, LLC. It displays the NDC 51655-403-52 and provides additional regulatory and packaging information including lot and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.